Proton pump inhibitors: Predisposers to Alzheimer disease?

Journal of Clinical Pharmacy and Therapeutics

Volumn 35, Issue 2, 2010, Pages 125-126

  Fallahzadeh, M K ^a   Borhani Haghighi, A ^b   Namazi, M R ^c  

^a Autoimmune Diseases Research Center   (United States)

^b Department of Neurology   (United States)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Amyloid beta; Lysosomes; Microglia; Vacuolar proton pumps

Indexed keywords

AMYLOID BETA PROTEIN; FIBRILLAR AMYLOID BETA PROTEIN; PROTON PUMP; PROTON PUMP INHIBITOR; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; DISEASE PREDISPOSITION; GASTROESOPHAGEAL REFLUX; HUMAN; LYSOSOME; MACROPHAGE; MICROGLIA; NOTE; RISK FACTOR;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; BLOOD-BRAIN BARRIER; HUMANS; MICROGLIA; PROTON PUMP INHIBITORS; RISK FACTORS; TIME FACTORS; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 77749336154     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2009.01100.x     Document Type: Note

References (7)

1. Gandy S (2005) The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease. The Journal of Clinical Investigation, 115, 1121 1129.
2. Archer HA, Edison P, Brooks DJ et al. (2006) Amyloid load and cerebral atrophy in Alzheimer's disease: an 11C-PIB positron emission tomography study. Annals of Neurology, 60, 145 147.
3. Majumdar A, Cruz D, Asamoah N, Buxbaum A, Sohar I, Lobel P, Maxfield FR (2007) Activation of microglia acidifies lysosomes and leads to degradation of Alzheimer amyloid fibrils. Molecular Biology of the Cell, 18, 1490 1496.
4. Namazi MR, Jowkar F (2008) A succinct review of the general and immunological pharmacologic effects of proton pump inhibitors. Journal of Clinical Pharmacy and Therapeutics, 33, 215 217.
5. Shi S, Klotz U (2008) Proton pump inhibitors: an update of their clinical use and pharmacokinetics. European Journal of Clinical Pharmacology, 64, 935 951.
6. Cheng FC, Ho YF, Hung LC, Chen CF, Tsai TH (2002) Determination and pharmacokinetic profile of omeprazole in rat blood, brain and bile by microdialysis and high-performance liquid chromatography. Journal of Chromatography A, 949, 35 42.
7. Shamburek RD, Schubert ML (1993) Pharmacology of gastric acid inhibition. Bailliere's Clinical Gastroenterology, 7, 23 54.